Clinical Trial Update: Efficacy/Safety of Human Plasminogen Eye Drop in Ligneous Conjunctivitis Patients [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on human plasminogen eye drops for ligneous conjunctivitis completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ligneous Conjunctivitis

Drugs mentioned

• Human plasminogen eye drop (plasminogen eye drop)

Snippet

Sponsor: Kedrion S.p.A. | Conditions: Ligneous Conjunctivitis | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2023-01-25